Abstract
Chapter 13 established that income is an important confounder of some air pollution-associated health effects: low income increases health risks and is also associated with living in areas having higher air pollution levels. This raises the public health question: would reducing air pollution levels without addressing the other correlates of low income that might contribute to increased health risks, be effective in reducing health risks? Decades of regulatory science and political opinion have answered this question loudly and repeatedly in the affirmative. As discussed in subsequent chapters, practical experience has been much less encouraging, with substantial reductions in air pollution often making no clear contribution to causing improved public health. However, notwithstanding this experience, media, regulatory, and advocacy reports and recommendations continue to overwhelmingly assert that fine particulate matter (PM2.5, i.e., particulate matter smaller than 2.5 μm in diameter) in outdoor air kills people and causes serious health problems. Regulatory proposals to further decrease currently permitted levels of pollutants are supported by reference to large estimated or predicted health benefits from doing so. For example, in early 2011, the EPA released the results of its cost-benefit analysis of the 1990 Clean Air Act Amendments (CAAA). The assessment made two striking claims (EPA 2011a): (1) As of 2020, the CAAA would produce estimated health benefits valued at approximately two trillion (i.e., two thousand billion) dollars per year, compared to estimated compliance costs of only about $65 billion/year; and (2) The uncertainties in the cost-benefit analysis are small enough so that, “The extent to which estimated benefits exceed estimated costs and an in-depth analysis of uncertainties indicate that it is extremely unlikely the costs of 1990 Clean Air Act Amendment programs would exceed their benefits under any reasonable combination of alternative assumptions or methods identified during this study” (emphasis in original).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010;7:216–25.
Aldy JE, Viscusi WK. Age differences in the value of statistical life: revealed preference evidence. Rev Environ Econ Policy. 2007;1(2):241–60.
Capewell S, Ford ES, Croft JB, Critchley JA, Greenlund KJ, Labarthe DR. Cardiodiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ. 2010;88(2):81–160.
Clyde M. Model uncertainty and health effect studies for particulate matter. Environmetrics. 2000;11(6):745–63.
Cox LA Jr. Reassessing the human health benefits from cleaner air. Risk Anal. 2012;32(5):816–29. https://doi.org/10.1111/j.1539-6924.2011.01698.x.
Daniels MJ, Dominici F, Samet JM, Zeger SL. Estimating particulate matter-mortality dose-response curves and threshold levels: an analysis of daily time-series for the 20 largest US cities. Am J Epidemiol. 2000;152(5):397–406.
EPA. The benefits and costs of the clean air act from 1990 to 2020: summary report. Washington, D.C.: U.S. EPA, Office of Air and Radiation; 2011a.
EPA. The benefits and costs of the clean air act from 1990 to 2020. Full report. Washington, D.C.: U.S. EPA, Office of Air and Radiation; 2011b.
Franklin M, Zeka A, Schwartz J. Association between PM2.5 and all-cause and specific-cause mortality in 27 US communities. J Expo Sci Environ Epidemiol. 2007;17(3):279–87.
Gold M, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
Gray GM, Cohen JT. Rethink chemical risk assessments. Nature. 2012;389:27–8.
Green LC, Armstrong SR. Particulate matter in ambient air and mortality: toxicologic perspectives. Regul Toxicol Pharmacol. 2003;38(3):32.
Koop G, Tole L. Measuring the health effects of air pollution: to what extent can we really say that people are dying from bad air? J Environ Econ Manag. 2004;47:30–54.
Koop G, Tole L. An investigation of thresholds in air pollution–mortality effects. Environ Model Softw. 2006;21(12):1662–73.
Krewski D, Jerrett M, Burnett RT, et al. Extended follow-up and spatial analysis of the American Cancer Society study linking particulate air pollution and mortality. Res Rep Health Eff Inst. 2009;140:5–114.
Laden F, Schwartz J, Speizer FE, Dockery DW. Reduction in fine particulate air pollution and mortality: Extended follow-up of the Harvard Six Cities study. Am J Respir Crit Care Med. 2006 Mar 15;173(6):667–72. https://doi.org/10.1164/rccm.200503-443OC. Epub 2006 Jan 19. PMID: 16424447; PMCID: PMC2662950.
Murphy K, Topel R. The economic value of medical research. In: Murphy K, Topel R, editors. Measuring the gains from economic research: an economic approach. Chicago: University of Chicago Press; 2003. p. 9–40.
Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002 Mar 6;287(9):1132–41. https://doi.org/10.1001/jama.287.9.1132. PMID: 11879110; PMCID: PMC4037163.
Roberts S, Martin MA. The question of nonlinearity in the dose-response relation between particulate matter air pollution and mortality: can Akaike’s Information Criterion be trusted to take the right turn? Am J Epidemiol. 2006;164(12):1242–50.
Schwartz J, Coull B, Laden F, Ryan L. The effect of dose and timing of dose on the association between airborne particles and survival. Environ Health Perspect. 2008;116(1):64–9.
Sheppard L, Burnett RT, Szpiro AA, Kim S-Y, Jerrett M, Pope CA, Brunekreef B. Confounding and exposure measurement error in air pollution. Air Qual Atmos Health. 2012;5(2):203–16.
Simkhovich BZ, Kleinman MT, Kloner RA. Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J Am Coll Cardiol. 2008;52(9):719–26.
Simkhovich BZ, Kleinman MT, Kloner RA. Particulate air pollution and coronary heart disease. Curr Opin Cardiol. 2009;24(6):604–9.
Stoeger T, Reinhard C, Takenaka S, Schroeppel A, Karg E, Ritter B, Heyder J, Schulz H. Instillation of six different ultrafine carbon particles indicates a surface area threshold dose for acute lung inflammation in mice. Environ Health Perspect. 2006;114(3):328–33.
Thomas DC, Jerrett M, Kuenzli N, Louis TA, Dominici F, Zeger S, Schwartz J, Burnett RT, Krewski D, Bates D. Bayesian model averaging in time-series studies of air pollution and mortality. J Toxicol Environ Health A. 2007;70(3-4):311–5.
Vitolo C, Scutari M, Ghalaieny M, Tucker A, Russell A. Modeling air pollution, climate, and health data using Bayesian Networks: a case study of the English regions. Earth Space Sci. 2018;5:76–88. https://doi.org/10.1002/2017EA000326.
Yabroff KR, Bradley CJ, Mariotto AB, Brown ML. Estimates and projections of value of life lost from cancer deaths in the United States. J Natl Cancer Inst. 2008;100(24):1755–62.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Cox Jr., L.A. (2021). How Realistic Are Estimates of Health Benefits from Air Pollution Control?. In: Quantitative Risk Analysis of Air Pollution Health Effects. International Series in Operations Research & Management Science, vol 299. Springer, Cham. https://doi.org/10.1007/978-3-030-57358-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-57358-4_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-57357-7
Online ISBN: 978-3-030-57358-4
eBook Packages: Business and ManagementBusiness and Management (R0)